omni
aaps
Prescribed Reading: Pharma Marked By Restructuring And Failures
Prescribed Reading: Pharma Marked By Restructuring And Failures
Biopharma is a complex, rapidly evolving industry that is highly regulated and closely watched - and that means there is constant news. Here's a closer look at the clinical trials, M&A, cool science and regulations that are driving the industry this week.
Modernizing the Pharmaceutical Manufacturing Base
Modernizing the Pharmaceutical Manufacturing Base
If we used a time machine to transport a pharmaceutical scientist from the 1960s into a current pharmaceutical production plant, it might be surprising to learn that he would already be familiar with most of the processes and production techniques bein...
FDA Releases Guidance to Assist Development of Advanced Technology to Modernize Pharmaceutical Ma...
FDA Releases Guidance to Assist Development of Advanced Technology to Modernize Pharmaceutical Ma...
On Dec. 23, 2015, the Food and Drug Administration (FDA) released draft guidance on the Advancement of Emerging Technology Applications to Modernize the Pharmaceutical Manufacturing Base. This was a positive step towards helping pharmaceutical companie...
Great Expectations: The Psychology of Switching From Brand Drugs To Generics
Great Expectations: The Psychology of Switching From Brand Drugs To Generics
The late Canadian novelist Robertson Davies once remarked that the eye sees only what the mind is prepared to comprehend. He could almost have been referring to oft-reported negative experiences of patients switching from branded to generic drugs.
Avoiding a CIA: Analytics And the Search For Dangerous Data
Avoiding a CIA: Analytics And the Search For Dangerous Data
When it comes to promoting compliance in the pharmaceutical industry, corporate integrity agreement may be the most important - and most onerous - tools in the government's toolbox.